Skip to main content
Neurology® Neuroimmunology & Neuroinflammation logoLink to Neurology® Neuroimmunology & Neuroinflammation
. 2016 Jul 25;3(4):e273. doi: 10.1212/NXI.0000000000000273

Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months

PMCID: PMC4974845  PMID: 27583275

In the article “Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months” by S. De Mercanti et al.,1 one of the individuals listed in the coinvestigator appendix met the criteria for authorship and therefore should have been listed as an author. The fourth author should be listed as “Daniela Taverna, BS, PhD (Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy). The authors regret the error.

REFERENCE

  • 1.De Mercanti S, Rolla S, Cucci A, et al. Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months. Neurol Neuroimmunol Neuroinflamm 2016;3:e194. doi: 10.1212/NXI.0000000000000194. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology® Neuroimmunology & Neuroinflammation are provided here courtesy of American Academy of Neurology

RESOURCES